Mot1 Activators
Mot1 Activators primarily consist of chemical compounds that have a direct or indirect impact on the specific pathways in which Mot1 is involved. These activators, including Trichostatin A, Sodium Butyrate, ICG-001, JQ1, MG132, 5-Azacytidine, Actinomycin D, C646, A-485, Vorinostat, Quisinostat, and Rocilinostat, can enhance the functional activity of Mot1 through specific signaling pathways.
Certain compounds, such as Trichostatin A, Sodium Butyrate, Vorinostat, Quisinostat, and Rocilinostat, operate through the histone deacetylase (HDAC) pathway, promoting histone acetylation and a more relaxed chromatin structure. This can enhance the functional activity of Mot1, which is involved in chromatin remodeling. Another category of compounds that influence Mot1 activity are those targeting the DNA methylation pathway, such as 5-Azacytidine, which inhibits DNA methylation, leading to a more open chromatin structure that can enhance Mot1 activity. Other compounds like MG132 and Actinomycin D inhibit the proteasome and RNA polymerase respectively, leading to anincrease in Mot1 activity by decreasing its degradation and triggering a compensatory response to increase transcriptional machinery activity. Likewise, ICG-001 could increase Mot1 activity by inhibiting this pathway and thereby increasing the activity of other transcriptional machineries. JQ1 is another compound that can indirectly enhance Mot1 activity. By blocking the binding of acetylated histones, it alters chromatin structure to enable Mot1, a chromatin remodeling factor, to function more effectively.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A is an inhibitor of histone deacetylases (HDACs). When HDACs are inhibited, acetylation of histones can occur, leading to a more open chromatin structure. This can enhance the activity of Mot1, which works to remodel chromatin and facilitate transcription. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
Sodium Butyrate is another HDAC inhibitor. By inhibiting HDACs, it promotes histone acetylation, leading to a more relaxed chromatin structure. This can enhance the functional activity of Mot1, which is involved in chromatin remodeling. | ||||||
(±)-JQ1 | 1268524-69-1 | sc-472932 sc-472932A | 5 mg 25 mg | $231.00 $863.00 | 1 | |
JQ1 is a bromodomain inhibitor that blocks binding of acetylated histones. This alteration in chromatin structure can enhance the activity of Mot1, a chromatin remodeling factor. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
MG132 is a proteasome inhibitor. By inhibiting proteasome activity, it can potentially lead to an increase in Mot1 activity by preventing its degradation, thus allowing Mot1 to continue performing its functions. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
5-Azacytidine is a DNA methyltransferase inhibitor. By inhibiting DNA methylation, it can lead to a more open chromatin structure. This can enhance the functional activity of Mot1, which is involved in chromatin remodeling. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Actinomycin D is an inhibitor of RNA polymerase. By inhibiting RNA polymerase, it could potentially enhance the functional activity of Mot1 as it could trigger a compensatory response to increase transcriptional machinery activity. | ||||||
C646 | 328968-36-1 | sc-364452 sc-364452A | 10 mg 50 mg | $265.00 $944.00 | 5 | |
C646 is a selective p300/CBP inhibitor. p300/CBP are histone acetyltransferases. By inhibiting these, C646 could trigger a compensatory response to increase other transcriptional machinery activities, including that of Mot1. | ||||||
A-485 | 1889279-16-6 | sc-507493 | 5 mg | $275.00 | ||
A-485 is a selective p300/CBP inhibitor. By inhibiting p300/CBP, it could trigger a compensatory response to increase other transcriptional machinery activities, including that of Mot1. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
Vorinostat is an HDAC inhibitor that promotes histone acetylation and a more relaxed chromatin structure. This can enhance the functional activity of Mot1, which is involved in chromatin remodeling. | ||||||
ACY-1215 | 1316214-52-4 | sc-507455 | 25 mg | $110.00 | ||
Rocilinostat is an HDAC inhibitor. By promoting histone acetylation, it leads to a more relaxed chromatin structure. This can enhance the functional activity of Mot1, which is involved in chromatin remodeling. | ||||||